We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App


Future COVID-19 Tests Could Be Based on Biomarkers and Molecular Profiles of Individuals

A new study has shown how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity. This could pave the way for better medical tests based on biomarkers and molecular profiles of individuals, to accommodate these variations in monitoring virus transmission and disease pathology, which helps guide mitigation and treatment options. More...
23 Oct 2020

New COVID-19 Mass Screening Method Could Be 20 Times Cheaper Than Individual Testing

Using a new mathematical approach to screen large groups for COVID-19 could be around 20 times cheaper than individual testing, suggests a study by researchers at The University of Edinburgh (Edinburgh, UK). More...
22 Oct 2020
BIOHIT  Healthcare OY
Image: BreathTest-1000™ mass spectrometer (Photo courtesy of Business Wire)

Mass Spectrometry-Based Device Uses Breath Samples to Rapidly Identify COVID-19 Strains

Scientists are leveraging mass spectrometry technology to develop a rapid, non-invasive device that will use breath samples to identify COVID-19 strains. More...
22 Oct 2020
Image: The POSTECH researchers designed the test kit to produce nucleic acid binding reaction to show fluorescence only when COVID-19 RNA is present (Photo courtesy of POSTECH)

New Simple, Portable and Easy-To-Use Technology Diagnoses COVID-19 Infection in Just 30 Minutes

A new one-pot diagnostic method for detecting pathogenic RNAs with PCR-level sensitivity allows anyone to easily and quickly diagnose COVID-19 in just 30 minutes. More...
22 Oct 2020

Rapid COVID-19 Antigen Tests Less Effective at Detecting SARS-CoV-2 in People with Low Virus Levels, Finds Study

Researchers from the Erasmus University Medical Center (Rotterdam, the Netherlands) have cautioned that not all rapid COVID-19 antigen tests that provide results within 30 minutes may be equally effective at detecting the SARS-CoV-2 virus. More...
22 Oct 2020
Image: VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit (Photo courtesy of Becton, Dickinson and Company)

CerTest Biotec and BD Secure CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX System

CerTest Biotec (Zaragoza, Spain), along with Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA), have announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit adapted for the BD MAX System has been CE marked. More...
22 Oct 2020

ThermoGenesis’ Breakthrough Lateral Flow Immunoassay Test Reader to Help Track Antibody Response of COVID-19 Vaccine Recipients

A new breakthrough lateral flow immunoassay test reader technology aims to facilitate the widespread use of inexpensive, mass-produced, FDA-authorized SARS-CoV-2 lateral flow immunoassay (LFIA) tests to distinguish seropositive members of populations of concern (individuals who already have SARS-CoV-2 antibodies), who might be a lower priority for the earliest immunization. More...
21 Oct 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.